Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
234.00
0.00 (0.00%)
Jan 22, 2026, 3:28 PM IST
NSE:MADHAVBAUG Revenue
Vaidya Sane Ayurved Laboratories had revenue of 499.44M INR in the half year ending September 30, 2025, a decrease of -2.26%. This brings the company's revenue in the last twelve months to 979.90M, up 8.84% year-over-year. In the fiscal year ending March 31, 2025, Vaidya Sane Ayurved Laboratories had annual revenue of 898.47M, down -9.55%.
Revenue (ttm)
979.90M
Revenue Growth
+8.84%
P/S Ratio
2.51
Revenue / Employee
1.54M
Employees
636
Market Cap
2.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 898.47M | -94.85M | -9.55% |
| Mar 31, 2024 | 993.31M | 1.62M | 0.16% |
| Mar 31, 2023 | 991.69M | 244.58M | 32.74% |
| Mar 31, 2022 | 747.11M | 224.36M | 42.92% |
| Mar 31, 2021 | 522.75M | -229.55M | -30.51% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 7.48B |
| Chemkart India | 1.93B |
| Rama Vision | 1.34B |
| Checkpoint Trends | 1.21B |
| Khemani Distributors & Marketing | 1.09B |
| VijayPD Ceutical | 1.07B |
| Novelix Pharmaceuticals | 849.03M |
| Medico Intercontinental | 822.95M |